The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only flu vaccine in ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. The FDA has signed off on the British drugmaker’s influenza vaccine FluMist for self-administration by ...

FluMist (influenza vaccine live, intranasal) is a brand-name vaccine that’s used to help prevent influenza infection (the flu) in adults and some children. FluMist comes as a nasal spray that’s given ...

AstraZeneca (AZN) launches the first FDA-approved influenza vaccine available for self- or caregiver administration, providing a convenient, household-based option for seasonal flu vaccination ...

If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults have a strong fear of needles. Enter FluMist, the nasal flu vaccine.

People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. AstraZeneca, which makes the ...

Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for ...

WILMINGTON, Del.--(BUSINESS WIRE)-- FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by ...

Eligible individuals will be able to have the vaccine shipped to their homes for self-administration. The Food and Drug Administration (FDA) has approved at-home self- or caregiver-administration of ...